Multifunctional engineered mesoporous silica/inorganic material hybrid nanoparticles: Theranostic perspectives
The field of advanced nanotechnology is brimming with a plethora of nanotheranostics whose combinatorial synergistic applicability in treating malignant tumors is tremendous. But such multifunctional systems do hold drawbacks that are primarily liable to the inherent nature as well as the properties...
Ausführliche Beschreibung
Autor*in: |
Fernandes, Neha Benedicta [verfasserIn] Nayak, Yogendra [verfasserIn] Garg, Sanjay [verfasserIn] Nayak, Usha Y [verfasserIn] |
---|
Format: |
E-Artikel |
---|---|
Sprache: |
Englisch |
Erschienen: |
2022 |
---|
Schlagwörter: |
---|
Übergeordnetes Werk: |
Enthalten in: Coordination chemistry reviews - Amsterdam [u.a.] : Elsevier Science, 1966, 478 |
---|---|
Übergeordnetes Werk: |
volume:478 |
DOI / URN: |
10.1016/j.ccr.2022.214977 |
---|
Katalog-ID: |
ELV009051309 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | ELV009051309 | ||
003 | DE-627 | ||
005 | 20230524142741.0 | ||
007 | cr uuu---uuuuu | ||
008 | 230510s2022 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.ccr.2022.214977 |2 doi | |
035 | |a (DE-627)ELV009051309 | ||
035 | |a (ELSEVIER)S0010-8545(22)00572-0 | ||
040 | |a DE-627 |b ger |c DE-627 |e rda | ||
041 | |a eng | ||
082 | 0 | 4 | |a 540 |q DE-600 |
084 | |a 35.00 |2 bkl | ||
100 | 1 | |a Fernandes, Neha Benedicta |e verfasserin |4 aut | |
245 | 1 | 0 | |a Multifunctional engineered mesoporous silica/inorganic material hybrid nanoparticles: Theranostic perspectives |
264 | 1 | |c 2022 | |
336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
520 | |a The field of advanced nanotechnology is brimming with a plethora of nanotheranostics whose combinatorial synergistic applicability in treating malignant tumors is tremendous. But such multifunctional systems do hold drawbacks that are primarily liable to the inherent nature as well as the properties of the incorporated nanoparticles, which can be effectively tackled by either substituting or incorporating molecules having higher biocompatibility and biodegradability profiles. So, one such sort after, highly exploited inorganic nanocarrier using which theranostic platforms are developed is the Mesoporous Silica Nanoparticle (MSNs), whose amalgamation with upconversion nanoparticles having cutting-edge Near-Infrared imaging proficiency is gaining eminence in biomedicine-based research owing to its exemplary properties in drug targeting, bio-imaging and photodynamic/photothermal therapy, that makes them interesting for further research. MSNs are versatile in aspects related to their pore size and nature, greater drug loading efficiency, and functionalization accentuating their applicability. Several constructive studies with MSNs have been attempted by researchers worldwide, whose manipulation ultimately serves the said purpose of achieving a more holistic approach to treating carcinomas. This article principally sheds light on MSN-based hybrid nanotheranostics such as MSN-Metal Nanoparticles, MSN-Quantum Dots, MSN-Carbon Nanotubes, MSN-Fullerenes, MSN-Graphenes/ Graphene Oxide, MSN-Persistent Luminescence Nanoparticles, and MSN-Carbon-Dots, along with their designing strategies, characterization, applications, in vitro and in vivo efficacy, limitations, biotoxicity as well as the current challenges and future perspectives. | ||
650 | 4 | |a Nanotheranostics | |
650 | 4 | |a Biocompatibility | |
650 | 4 | |a Biodegradability | |
650 | 4 | |a Multifunctional systems | |
650 | 4 | |a Mesoporous silica nanoparticles | |
650 | 4 | |a Upconversion nanoparticles | |
700 | 1 | |a Nayak, Yogendra |e verfasserin |4 aut | |
700 | 1 | |a Garg, Sanjay |e verfasserin |4 aut | |
700 | 1 | |a Nayak, Usha Y |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Coordination chemistry reviews |d Amsterdam [u.a.] : Elsevier Science, 1966 |g 478 |h Online-Ressource |w (DE-627)306655020 |w (DE-600)1499984-5 |w (DE-576)081985002 |x 0010-8545 |7 nnns |
773 | 1 | 8 | |g volume:478 |
912 | |a GBV_USEFLAG_U | ||
912 | |a SYSFLAG_U | ||
912 | |a GBV_ELV | ||
912 | |a SSG-OLC-PHA | ||
912 | |a GBV_ILN_20 | ||
912 | |a GBV_ILN_22 | ||
912 | |a GBV_ILN_23 | ||
912 | |a GBV_ILN_24 | ||
912 | |a GBV_ILN_31 | ||
912 | |a GBV_ILN_32 | ||
912 | |a GBV_ILN_40 | ||
912 | |a GBV_ILN_60 | ||
912 | |a GBV_ILN_62 | ||
912 | |a GBV_ILN_63 | ||
912 | |a GBV_ILN_69 | ||
912 | |a GBV_ILN_70 | ||
912 | |a GBV_ILN_73 | ||
912 | |a GBV_ILN_74 | ||
912 | |a GBV_ILN_90 | ||
912 | |a GBV_ILN_95 | ||
912 | |a GBV_ILN_100 | ||
912 | |a GBV_ILN_101 | ||
912 | |a GBV_ILN_105 | ||
912 | |a GBV_ILN_110 | ||
912 | |a GBV_ILN_150 | ||
912 | |a GBV_ILN_151 | ||
912 | |a GBV_ILN_224 | ||
912 | |a GBV_ILN_370 | ||
912 | |a GBV_ILN_602 | ||
912 | |a GBV_ILN_702 | ||
912 | |a GBV_ILN_2003 | ||
912 | |a GBV_ILN_2004 | ||
912 | |a GBV_ILN_2005 | ||
912 | |a GBV_ILN_2011 | ||
912 | |a GBV_ILN_2014 | ||
912 | |a GBV_ILN_2015 | ||
912 | |a GBV_ILN_2020 | ||
912 | |a GBV_ILN_2021 | ||
912 | |a GBV_ILN_2025 | ||
912 | |a GBV_ILN_2027 | ||
912 | |a GBV_ILN_2034 | ||
912 | |a GBV_ILN_2038 | ||
912 | |a GBV_ILN_2044 | ||
912 | |a GBV_ILN_2048 | ||
912 | |a GBV_ILN_2049 | ||
912 | |a GBV_ILN_2050 | ||
912 | |a GBV_ILN_2056 | ||
912 | |a GBV_ILN_2059 | ||
912 | |a GBV_ILN_2061 | ||
912 | |a GBV_ILN_2064 | ||
912 | |a GBV_ILN_2065 | ||
912 | |a GBV_ILN_2068 | ||
912 | |a GBV_ILN_2111 | ||
912 | |a GBV_ILN_2112 | ||
912 | |a GBV_ILN_2113 | ||
912 | |a GBV_ILN_2118 | ||
912 | |a GBV_ILN_2122 | ||
912 | |a GBV_ILN_2129 | ||
912 | |a GBV_ILN_2143 | ||
912 | |a GBV_ILN_2147 | ||
912 | |a GBV_ILN_2148 | ||
912 | |a GBV_ILN_2152 | ||
912 | |a GBV_ILN_2153 | ||
912 | |a GBV_ILN_2190 | ||
912 | |a GBV_ILN_2336 | ||
912 | |a GBV_ILN_2507 | ||
912 | |a GBV_ILN_2522 | ||
912 | |a GBV_ILN_4035 | ||
912 | |a GBV_ILN_4037 | ||
912 | |a GBV_ILN_4112 | ||
912 | |a GBV_ILN_4125 | ||
912 | |a GBV_ILN_4126 | ||
912 | |a GBV_ILN_4242 | ||
912 | |a GBV_ILN_4251 | ||
912 | |a GBV_ILN_4305 | ||
912 | |a GBV_ILN_4313 | ||
912 | |a GBV_ILN_4323 | ||
912 | |a GBV_ILN_4324 | ||
912 | |a GBV_ILN_4325 | ||
912 | |a GBV_ILN_4326 | ||
912 | |a GBV_ILN_4333 | ||
912 | |a GBV_ILN_4334 | ||
912 | |a GBV_ILN_4335 | ||
912 | |a GBV_ILN_4338 | ||
912 | |a GBV_ILN_4393 | ||
936 | b | k | |a 35.00 |j Chemie: Allgemeines |
951 | |a AR | ||
952 | |d 478 |
author_variant |
n b f nb nbf y n yn s g sg u y n uy uyn |
---|---|
matchkey_str |
article:00108545:2022----::utfntoaegneemspruslciogncaeilyrdaoatc |
hierarchy_sort_str |
2022 |
bklnumber |
35.00 |
publishDate |
2022 |
allfields |
10.1016/j.ccr.2022.214977 doi (DE-627)ELV009051309 (ELSEVIER)S0010-8545(22)00572-0 DE-627 ger DE-627 rda eng 540 DE-600 35.00 bkl Fernandes, Neha Benedicta verfasserin aut Multifunctional engineered mesoporous silica/inorganic material hybrid nanoparticles: Theranostic perspectives 2022 nicht spezifiziert zzz rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier The field of advanced nanotechnology is brimming with a plethora of nanotheranostics whose combinatorial synergistic applicability in treating malignant tumors is tremendous. But such multifunctional systems do hold drawbacks that are primarily liable to the inherent nature as well as the properties of the incorporated nanoparticles, which can be effectively tackled by either substituting or incorporating molecules having higher biocompatibility and biodegradability profiles. So, one such sort after, highly exploited inorganic nanocarrier using which theranostic platforms are developed is the Mesoporous Silica Nanoparticle (MSNs), whose amalgamation with upconversion nanoparticles having cutting-edge Near-Infrared imaging proficiency is gaining eminence in biomedicine-based research owing to its exemplary properties in drug targeting, bio-imaging and photodynamic/photothermal therapy, that makes them interesting for further research. MSNs are versatile in aspects related to their pore size and nature, greater drug loading efficiency, and functionalization accentuating their applicability. Several constructive studies with MSNs have been attempted by researchers worldwide, whose manipulation ultimately serves the said purpose of achieving a more holistic approach to treating carcinomas. This article principally sheds light on MSN-based hybrid nanotheranostics such as MSN-Metal Nanoparticles, MSN-Quantum Dots, MSN-Carbon Nanotubes, MSN-Fullerenes, MSN-Graphenes/ Graphene Oxide, MSN-Persistent Luminescence Nanoparticles, and MSN-Carbon-Dots, along with their designing strategies, characterization, applications, in vitro and in vivo efficacy, limitations, biotoxicity as well as the current challenges and future perspectives. Nanotheranostics Biocompatibility Biodegradability Multifunctional systems Mesoporous silica nanoparticles Upconversion nanoparticles Nayak, Yogendra verfasserin aut Garg, Sanjay verfasserin aut Nayak, Usha Y verfasserin aut Enthalten in Coordination chemistry reviews Amsterdam [u.a.] : Elsevier Science, 1966 478 Online-Ressource (DE-627)306655020 (DE-600)1499984-5 (DE-576)081985002 0010-8545 nnns volume:478 GBV_USEFLAG_U SYSFLAG_U GBV_ELV SSG-OLC-PHA GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_32 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_69 GBV_ILN_70 GBV_ILN_73 GBV_ILN_74 GBV_ILN_90 GBV_ILN_95 GBV_ILN_100 GBV_ILN_101 GBV_ILN_105 GBV_ILN_110 GBV_ILN_150 GBV_ILN_151 GBV_ILN_224 GBV_ILN_370 GBV_ILN_602 GBV_ILN_702 GBV_ILN_2003 GBV_ILN_2004 GBV_ILN_2005 GBV_ILN_2011 GBV_ILN_2014 GBV_ILN_2015 GBV_ILN_2020 GBV_ILN_2021 GBV_ILN_2025 GBV_ILN_2027 GBV_ILN_2034 GBV_ILN_2038 GBV_ILN_2044 GBV_ILN_2048 GBV_ILN_2049 GBV_ILN_2050 GBV_ILN_2056 GBV_ILN_2059 GBV_ILN_2061 GBV_ILN_2064 GBV_ILN_2065 GBV_ILN_2068 GBV_ILN_2111 GBV_ILN_2112 GBV_ILN_2113 GBV_ILN_2118 GBV_ILN_2122 GBV_ILN_2129 GBV_ILN_2143 GBV_ILN_2147 GBV_ILN_2148 GBV_ILN_2152 GBV_ILN_2153 GBV_ILN_2190 GBV_ILN_2336 GBV_ILN_2507 GBV_ILN_2522 GBV_ILN_4035 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4242 GBV_ILN_4251 GBV_ILN_4305 GBV_ILN_4313 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4326 GBV_ILN_4333 GBV_ILN_4334 GBV_ILN_4335 GBV_ILN_4338 GBV_ILN_4393 35.00 Chemie: Allgemeines AR 478 |
spelling |
10.1016/j.ccr.2022.214977 doi (DE-627)ELV009051309 (ELSEVIER)S0010-8545(22)00572-0 DE-627 ger DE-627 rda eng 540 DE-600 35.00 bkl Fernandes, Neha Benedicta verfasserin aut Multifunctional engineered mesoporous silica/inorganic material hybrid nanoparticles: Theranostic perspectives 2022 nicht spezifiziert zzz rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier The field of advanced nanotechnology is brimming with a plethora of nanotheranostics whose combinatorial synergistic applicability in treating malignant tumors is tremendous. But such multifunctional systems do hold drawbacks that are primarily liable to the inherent nature as well as the properties of the incorporated nanoparticles, which can be effectively tackled by either substituting or incorporating molecules having higher biocompatibility and biodegradability profiles. So, one such sort after, highly exploited inorganic nanocarrier using which theranostic platforms are developed is the Mesoporous Silica Nanoparticle (MSNs), whose amalgamation with upconversion nanoparticles having cutting-edge Near-Infrared imaging proficiency is gaining eminence in biomedicine-based research owing to its exemplary properties in drug targeting, bio-imaging and photodynamic/photothermal therapy, that makes them interesting for further research. MSNs are versatile in aspects related to their pore size and nature, greater drug loading efficiency, and functionalization accentuating their applicability. Several constructive studies with MSNs have been attempted by researchers worldwide, whose manipulation ultimately serves the said purpose of achieving a more holistic approach to treating carcinomas. This article principally sheds light on MSN-based hybrid nanotheranostics such as MSN-Metal Nanoparticles, MSN-Quantum Dots, MSN-Carbon Nanotubes, MSN-Fullerenes, MSN-Graphenes/ Graphene Oxide, MSN-Persistent Luminescence Nanoparticles, and MSN-Carbon-Dots, along with their designing strategies, characterization, applications, in vitro and in vivo efficacy, limitations, biotoxicity as well as the current challenges and future perspectives. Nanotheranostics Biocompatibility Biodegradability Multifunctional systems Mesoporous silica nanoparticles Upconversion nanoparticles Nayak, Yogendra verfasserin aut Garg, Sanjay verfasserin aut Nayak, Usha Y verfasserin aut Enthalten in Coordination chemistry reviews Amsterdam [u.a.] : Elsevier Science, 1966 478 Online-Ressource (DE-627)306655020 (DE-600)1499984-5 (DE-576)081985002 0010-8545 nnns volume:478 GBV_USEFLAG_U SYSFLAG_U GBV_ELV SSG-OLC-PHA GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_32 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_69 GBV_ILN_70 GBV_ILN_73 GBV_ILN_74 GBV_ILN_90 GBV_ILN_95 GBV_ILN_100 GBV_ILN_101 GBV_ILN_105 GBV_ILN_110 GBV_ILN_150 GBV_ILN_151 GBV_ILN_224 GBV_ILN_370 GBV_ILN_602 GBV_ILN_702 GBV_ILN_2003 GBV_ILN_2004 GBV_ILN_2005 GBV_ILN_2011 GBV_ILN_2014 GBV_ILN_2015 GBV_ILN_2020 GBV_ILN_2021 GBV_ILN_2025 GBV_ILN_2027 GBV_ILN_2034 GBV_ILN_2038 GBV_ILN_2044 GBV_ILN_2048 GBV_ILN_2049 GBV_ILN_2050 GBV_ILN_2056 GBV_ILN_2059 GBV_ILN_2061 GBV_ILN_2064 GBV_ILN_2065 GBV_ILN_2068 GBV_ILN_2111 GBV_ILN_2112 GBV_ILN_2113 GBV_ILN_2118 GBV_ILN_2122 GBV_ILN_2129 GBV_ILN_2143 GBV_ILN_2147 GBV_ILN_2148 GBV_ILN_2152 GBV_ILN_2153 GBV_ILN_2190 GBV_ILN_2336 GBV_ILN_2507 GBV_ILN_2522 GBV_ILN_4035 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4242 GBV_ILN_4251 GBV_ILN_4305 GBV_ILN_4313 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4326 GBV_ILN_4333 GBV_ILN_4334 GBV_ILN_4335 GBV_ILN_4338 GBV_ILN_4393 35.00 Chemie: Allgemeines AR 478 |
allfields_unstemmed |
10.1016/j.ccr.2022.214977 doi (DE-627)ELV009051309 (ELSEVIER)S0010-8545(22)00572-0 DE-627 ger DE-627 rda eng 540 DE-600 35.00 bkl Fernandes, Neha Benedicta verfasserin aut Multifunctional engineered mesoporous silica/inorganic material hybrid nanoparticles: Theranostic perspectives 2022 nicht spezifiziert zzz rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier The field of advanced nanotechnology is brimming with a plethora of nanotheranostics whose combinatorial synergistic applicability in treating malignant tumors is tremendous. But such multifunctional systems do hold drawbacks that are primarily liable to the inherent nature as well as the properties of the incorporated nanoparticles, which can be effectively tackled by either substituting or incorporating molecules having higher biocompatibility and biodegradability profiles. So, one such sort after, highly exploited inorganic nanocarrier using which theranostic platforms are developed is the Mesoporous Silica Nanoparticle (MSNs), whose amalgamation with upconversion nanoparticles having cutting-edge Near-Infrared imaging proficiency is gaining eminence in biomedicine-based research owing to its exemplary properties in drug targeting, bio-imaging and photodynamic/photothermal therapy, that makes them interesting for further research. MSNs are versatile in aspects related to their pore size and nature, greater drug loading efficiency, and functionalization accentuating their applicability. Several constructive studies with MSNs have been attempted by researchers worldwide, whose manipulation ultimately serves the said purpose of achieving a more holistic approach to treating carcinomas. This article principally sheds light on MSN-based hybrid nanotheranostics such as MSN-Metal Nanoparticles, MSN-Quantum Dots, MSN-Carbon Nanotubes, MSN-Fullerenes, MSN-Graphenes/ Graphene Oxide, MSN-Persistent Luminescence Nanoparticles, and MSN-Carbon-Dots, along with their designing strategies, characterization, applications, in vitro and in vivo efficacy, limitations, biotoxicity as well as the current challenges and future perspectives. Nanotheranostics Biocompatibility Biodegradability Multifunctional systems Mesoporous silica nanoparticles Upconversion nanoparticles Nayak, Yogendra verfasserin aut Garg, Sanjay verfasserin aut Nayak, Usha Y verfasserin aut Enthalten in Coordination chemistry reviews Amsterdam [u.a.] : Elsevier Science, 1966 478 Online-Ressource (DE-627)306655020 (DE-600)1499984-5 (DE-576)081985002 0010-8545 nnns volume:478 GBV_USEFLAG_U SYSFLAG_U GBV_ELV SSG-OLC-PHA GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_32 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_69 GBV_ILN_70 GBV_ILN_73 GBV_ILN_74 GBV_ILN_90 GBV_ILN_95 GBV_ILN_100 GBV_ILN_101 GBV_ILN_105 GBV_ILN_110 GBV_ILN_150 GBV_ILN_151 GBV_ILN_224 GBV_ILN_370 GBV_ILN_602 GBV_ILN_702 GBV_ILN_2003 GBV_ILN_2004 GBV_ILN_2005 GBV_ILN_2011 GBV_ILN_2014 GBV_ILN_2015 GBV_ILN_2020 GBV_ILN_2021 GBV_ILN_2025 GBV_ILN_2027 GBV_ILN_2034 GBV_ILN_2038 GBV_ILN_2044 GBV_ILN_2048 GBV_ILN_2049 GBV_ILN_2050 GBV_ILN_2056 GBV_ILN_2059 GBV_ILN_2061 GBV_ILN_2064 GBV_ILN_2065 GBV_ILN_2068 GBV_ILN_2111 GBV_ILN_2112 GBV_ILN_2113 GBV_ILN_2118 GBV_ILN_2122 GBV_ILN_2129 GBV_ILN_2143 GBV_ILN_2147 GBV_ILN_2148 GBV_ILN_2152 GBV_ILN_2153 GBV_ILN_2190 GBV_ILN_2336 GBV_ILN_2507 GBV_ILN_2522 GBV_ILN_4035 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4242 GBV_ILN_4251 GBV_ILN_4305 GBV_ILN_4313 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4326 GBV_ILN_4333 GBV_ILN_4334 GBV_ILN_4335 GBV_ILN_4338 GBV_ILN_4393 35.00 Chemie: Allgemeines AR 478 |
allfieldsGer |
10.1016/j.ccr.2022.214977 doi (DE-627)ELV009051309 (ELSEVIER)S0010-8545(22)00572-0 DE-627 ger DE-627 rda eng 540 DE-600 35.00 bkl Fernandes, Neha Benedicta verfasserin aut Multifunctional engineered mesoporous silica/inorganic material hybrid nanoparticles: Theranostic perspectives 2022 nicht spezifiziert zzz rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier The field of advanced nanotechnology is brimming with a plethora of nanotheranostics whose combinatorial synergistic applicability in treating malignant tumors is tremendous. But such multifunctional systems do hold drawbacks that are primarily liable to the inherent nature as well as the properties of the incorporated nanoparticles, which can be effectively tackled by either substituting or incorporating molecules having higher biocompatibility and biodegradability profiles. So, one such sort after, highly exploited inorganic nanocarrier using which theranostic platforms are developed is the Mesoporous Silica Nanoparticle (MSNs), whose amalgamation with upconversion nanoparticles having cutting-edge Near-Infrared imaging proficiency is gaining eminence in biomedicine-based research owing to its exemplary properties in drug targeting, bio-imaging and photodynamic/photothermal therapy, that makes them interesting for further research. MSNs are versatile in aspects related to their pore size and nature, greater drug loading efficiency, and functionalization accentuating their applicability. Several constructive studies with MSNs have been attempted by researchers worldwide, whose manipulation ultimately serves the said purpose of achieving a more holistic approach to treating carcinomas. This article principally sheds light on MSN-based hybrid nanotheranostics such as MSN-Metal Nanoparticles, MSN-Quantum Dots, MSN-Carbon Nanotubes, MSN-Fullerenes, MSN-Graphenes/ Graphene Oxide, MSN-Persistent Luminescence Nanoparticles, and MSN-Carbon-Dots, along with their designing strategies, characterization, applications, in vitro and in vivo efficacy, limitations, biotoxicity as well as the current challenges and future perspectives. Nanotheranostics Biocompatibility Biodegradability Multifunctional systems Mesoporous silica nanoparticles Upconversion nanoparticles Nayak, Yogendra verfasserin aut Garg, Sanjay verfasserin aut Nayak, Usha Y verfasserin aut Enthalten in Coordination chemistry reviews Amsterdam [u.a.] : Elsevier Science, 1966 478 Online-Ressource (DE-627)306655020 (DE-600)1499984-5 (DE-576)081985002 0010-8545 nnns volume:478 GBV_USEFLAG_U SYSFLAG_U GBV_ELV SSG-OLC-PHA GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_32 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_69 GBV_ILN_70 GBV_ILN_73 GBV_ILN_74 GBV_ILN_90 GBV_ILN_95 GBV_ILN_100 GBV_ILN_101 GBV_ILN_105 GBV_ILN_110 GBV_ILN_150 GBV_ILN_151 GBV_ILN_224 GBV_ILN_370 GBV_ILN_602 GBV_ILN_702 GBV_ILN_2003 GBV_ILN_2004 GBV_ILN_2005 GBV_ILN_2011 GBV_ILN_2014 GBV_ILN_2015 GBV_ILN_2020 GBV_ILN_2021 GBV_ILN_2025 GBV_ILN_2027 GBV_ILN_2034 GBV_ILN_2038 GBV_ILN_2044 GBV_ILN_2048 GBV_ILN_2049 GBV_ILN_2050 GBV_ILN_2056 GBV_ILN_2059 GBV_ILN_2061 GBV_ILN_2064 GBV_ILN_2065 GBV_ILN_2068 GBV_ILN_2111 GBV_ILN_2112 GBV_ILN_2113 GBV_ILN_2118 GBV_ILN_2122 GBV_ILN_2129 GBV_ILN_2143 GBV_ILN_2147 GBV_ILN_2148 GBV_ILN_2152 GBV_ILN_2153 GBV_ILN_2190 GBV_ILN_2336 GBV_ILN_2507 GBV_ILN_2522 GBV_ILN_4035 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4242 GBV_ILN_4251 GBV_ILN_4305 GBV_ILN_4313 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4326 GBV_ILN_4333 GBV_ILN_4334 GBV_ILN_4335 GBV_ILN_4338 GBV_ILN_4393 35.00 Chemie: Allgemeines AR 478 |
allfieldsSound |
10.1016/j.ccr.2022.214977 doi (DE-627)ELV009051309 (ELSEVIER)S0010-8545(22)00572-0 DE-627 ger DE-627 rda eng 540 DE-600 35.00 bkl Fernandes, Neha Benedicta verfasserin aut Multifunctional engineered mesoporous silica/inorganic material hybrid nanoparticles: Theranostic perspectives 2022 nicht spezifiziert zzz rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier The field of advanced nanotechnology is brimming with a plethora of nanotheranostics whose combinatorial synergistic applicability in treating malignant tumors is tremendous. But such multifunctional systems do hold drawbacks that are primarily liable to the inherent nature as well as the properties of the incorporated nanoparticles, which can be effectively tackled by either substituting or incorporating molecules having higher biocompatibility and biodegradability profiles. So, one such sort after, highly exploited inorganic nanocarrier using which theranostic platforms are developed is the Mesoporous Silica Nanoparticle (MSNs), whose amalgamation with upconversion nanoparticles having cutting-edge Near-Infrared imaging proficiency is gaining eminence in biomedicine-based research owing to its exemplary properties in drug targeting, bio-imaging and photodynamic/photothermal therapy, that makes them interesting for further research. MSNs are versatile in aspects related to their pore size and nature, greater drug loading efficiency, and functionalization accentuating their applicability. Several constructive studies with MSNs have been attempted by researchers worldwide, whose manipulation ultimately serves the said purpose of achieving a more holistic approach to treating carcinomas. This article principally sheds light on MSN-based hybrid nanotheranostics such as MSN-Metal Nanoparticles, MSN-Quantum Dots, MSN-Carbon Nanotubes, MSN-Fullerenes, MSN-Graphenes/ Graphene Oxide, MSN-Persistent Luminescence Nanoparticles, and MSN-Carbon-Dots, along with their designing strategies, characterization, applications, in vitro and in vivo efficacy, limitations, biotoxicity as well as the current challenges and future perspectives. Nanotheranostics Biocompatibility Biodegradability Multifunctional systems Mesoporous silica nanoparticles Upconversion nanoparticles Nayak, Yogendra verfasserin aut Garg, Sanjay verfasserin aut Nayak, Usha Y verfasserin aut Enthalten in Coordination chemistry reviews Amsterdam [u.a.] : Elsevier Science, 1966 478 Online-Ressource (DE-627)306655020 (DE-600)1499984-5 (DE-576)081985002 0010-8545 nnns volume:478 GBV_USEFLAG_U SYSFLAG_U GBV_ELV SSG-OLC-PHA GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_32 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_69 GBV_ILN_70 GBV_ILN_73 GBV_ILN_74 GBV_ILN_90 GBV_ILN_95 GBV_ILN_100 GBV_ILN_101 GBV_ILN_105 GBV_ILN_110 GBV_ILN_150 GBV_ILN_151 GBV_ILN_224 GBV_ILN_370 GBV_ILN_602 GBV_ILN_702 GBV_ILN_2003 GBV_ILN_2004 GBV_ILN_2005 GBV_ILN_2011 GBV_ILN_2014 GBV_ILN_2015 GBV_ILN_2020 GBV_ILN_2021 GBV_ILN_2025 GBV_ILN_2027 GBV_ILN_2034 GBV_ILN_2038 GBV_ILN_2044 GBV_ILN_2048 GBV_ILN_2049 GBV_ILN_2050 GBV_ILN_2056 GBV_ILN_2059 GBV_ILN_2061 GBV_ILN_2064 GBV_ILN_2065 GBV_ILN_2068 GBV_ILN_2111 GBV_ILN_2112 GBV_ILN_2113 GBV_ILN_2118 GBV_ILN_2122 GBV_ILN_2129 GBV_ILN_2143 GBV_ILN_2147 GBV_ILN_2148 GBV_ILN_2152 GBV_ILN_2153 GBV_ILN_2190 GBV_ILN_2336 GBV_ILN_2507 GBV_ILN_2522 GBV_ILN_4035 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4242 GBV_ILN_4251 GBV_ILN_4305 GBV_ILN_4313 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4326 GBV_ILN_4333 GBV_ILN_4334 GBV_ILN_4335 GBV_ILN_4338 GBV_ILN_4393 35.00 Chemie: Allgemeines AR 478 |
language |
English |
source |
Enthalten in Coordination chemistry reviews 478 volume:478 |
sourceStr |
Enthalten in Coordination chemistry reviews 478 volume:478 |
format_phy_str_mv |
Article |
bklname |
Chemie: Allgemeines |
institution |
findex.gbv.de |
topic_facet |
Nanotheranostics Biocompatibility Biodegradability Multifunctional systems Mesoporous silica nanoparticles Upconversion nanoparticles |
dewey-raw |
540 |
isfreeaccess_bool |
false |
container_title |
Coordination chemistry reviews |
authorswithroles_txt_mv |
Fernandes, Neha Benedicta @@aut@@ Nayak, Yogendra @@aut@@ Garg, Sanjay @@aut@@ Nayak, Usha Y @@aut@@ |
publishDateDaySort_date |
2022-01-01T00:00:00Z |
hierarchy_top_id |
306655020 |
dewey-sort |
3540 |
id |
ELV009051309 |
language_de |
englisch |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV009051309</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230524142741.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230510s2022 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.ccr.2022.214977</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV009051309</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0010-8545(22)00572-0</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">540</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">35.00</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Fernandes, Neha Benedicta</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Multifunctional engineered mesoporous silica/inorganic material hybrid nanoparticles: Theranostic perspectives</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2022</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">The field of advanced nanotechnology is brimming with a plethora of nanotheranostics whose combinatorial synergistic applicability in treating malignant tumors is tremendous. But such multifunctional systems do hold drawbacks that are primarily liable to the inherent nature as well as the properties of the incorporated nanoparticles, which can be effectively tackled by either substituting or incorporating molecules having higher biocompatibility and biodegradability profiles. So, one such sort after, highly exploited inorganic nanocarrier using which theranostic platforms are developed is the Mesoporous Silica Nanoparticle (MSNs), whose amalgamation with upconversion nanoparticles having cutting-edge Near-Infrared imaging proficiency is gaining eminence in biomedicine-based research owing to its exemplary properties in drug targeting, bio-imaging and photodynamic/photothermal therapy, that makes them interesting for further research. MSNs are versatile in aspects related to their pore size and nature, greater drug loading efficiency, and functionalization accentuating their applicability. Several constructive studies with MSNs have been attempted by researchers worldwide, whose manipulation ultimately serves the said purpose of achieving a more holistic approach to treating carcinomas. This article principally sheds light on MSN-based hybrid nanotheranostics such as MSN-Metal Nanoparticles, MSN-Quantum Dots, MSN-Carbon Nanotubes, MSN-Fullerenes, MSN-Graphenes/ Graphene Oxide, MSN-Persistent Luminescence Nanoparticles, and MSN-Carbon-Dots, along with their designing strategies, characterization, applications, in vitro and in vivo efficacy, limitations, biotoxicity as well as the current challenges and future perspectives.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Nanotheranostics</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Biocompatibility</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Biodegradability</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Multifunctional systems</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Mesoporous silica nanoparticles</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Upconversion nanoparticles</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Nayak, Yogendra</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Garg, Sanjay</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Nayak, Usha Y</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Coordination chemistry reviews</subfield><subfield code="d">Amsterdam [u.a.] : Elsevier Science, 1966</subfield><subfield code="g">478</subfield><subfield code="h">Online-Ressource</subfield><subfield code="w">(DE-627)306655020</subfield><subfield code="w">(DE-600)1499984-5</subfield><subfield code="w">(DE-576)081985002</subfield><subfield code="x">0010-8545</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:478</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_23</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_31</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_32</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_60</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_62</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_63</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_69</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_70</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_73</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_74</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_90</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_95</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_100</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_101</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_105</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_110</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_150</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_151</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_224</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_370</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_602</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_702</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2003</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2004</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2005</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2011</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2014</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2015</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2020</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2021</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2025</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2027</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2034</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2038</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2044</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2048</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2049</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2050</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2056</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2059</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2061</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2064</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2065</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2068</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2111</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2112</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2113</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2118</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2122</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2129</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2143</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2147</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2148</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2152</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2153</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2190</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2336</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2507</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2522</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4035</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4037</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4112</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4125</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4126</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4242</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4251</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4313</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4323</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4324</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4325</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4326</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4333</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4334</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4335</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4338</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4393</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">35.00</subfield><subfield code="j">Chemie: Allgemeines</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">478</subfield></datafield></record></collection>
|
author |
Fernandes, Neha Benedicta |
spellingShingle |
Fernandes, Neha Benedicta ddc 540 bkl 35.00 misc Nanotheranostics misc Biocompatibility misc Biodegradability misc Multifunctional systems misc Mesoporous silica nanoparticles misc Upconversion nanoparticles Multifunctional engineered mesoporous silica/inorganic material hybrid nanoparticles: Theranostic perspectives |
authorStr |
Fernandes, Neha Benedicta |
ppnlink_with_tag_str_mv |
@@773@@(DE-627)306655020 |
format |
electronic Article |
dewey-ones |
540 - Chemistry & allied sciences |
delete_txt_mv |
keep |
author_role |
aut aut aut aut |
collection |
elsevier |
remote_str |
true |
illustrated |
Not Illustrated |
issn |
0010-8545 |
topic_title |
540 DE-600 35.00 bkl Multifunctional engineered mesoporous silica/inorganic material hybrid nanoparticles: Theranostic perspectives Nanotheranostics Biocompatibility Biodegradability Multifunctional systems Mesoporous silica nanoparticles Upconversion nanoparticles |
topic |
ddc 540 bkl 35.00 misc Nanotheranostics misc Biocompatibility misc Biodegradability misc Multifunctional systems misc Mesoporous silica nanoparticles misc Upconversion nanoparticles |
topic_unstemmed |
ddc 540 bkl 35.00 misc Nanotheranostics misc Biocompatibility misc Biodegradability misc Multifunctional systems misc Mesoporous silica nanoparticles misc Upconversion nanoparticles |
topic_browse |
ddc 540 bkl 35.00 misc Nanotheranostics misc Biocompatibility misc Biodegradability misc Multifunctional systems misc Mesoporous silica nanoparticles misc Upconversion nanoparticles |
format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
format_main_str_mv |
Text Zeitschrift/Artikel |
carriertype_str_mv |
cr |
hierarchy_parent_title |
Coordination chemistry reviews |
hierarchy_parent_id |
306655020 |
dewey-tens |
540 - Chemistry |
hierarchy_top_title |
Coordination chemistry reviews |
isfreeaccess_txt |
false |
familylinks_str_mv |
(DE-627)306655020 (DE-600)1499984-5 (DE-576)081985002 |
title |
Multifunctional engineered mesoporous silica/inorganic material hybrid nanoparticles: Theranostic perspectives |
ctrlnum |
(DE-627)ELV009051309 (ELSEVIER)S0010-8545(22)00572-0 |
title_full |
Multifunctional engineered mesoporous silica/inorganic material hybrid nanoparticles: Theranostic perspectives |
author_sort |
Fernandes, Neha Benedicta |
journal |
Coordination chemistry reviews |
journalStr |
Coordination chemistry reviews |
lang_code |
eng |
isOA_bool |
false |
dewey-hundreds |
500 - Science |
recordtype |
marc |
publishDateSort |
2022 |
contenttype_str_mv |
zzz |
author_browse |
Fernandes, Neha Benedicta Nayak, Yogendra Garg, Sanjay Nayak, Usha Y |
container_volume |
478 |
class |
540 DE-600 35.00 bkl |
format_se |
Elektronische Aufsätze |
author-letter |
Fernandes, Neha Benedicta |
doi_str_mv |
10.1016/j.ccr.2022.214977 |
dewey-full |
540 |
author2-role |
verfasserin |
title_sort |
multifunctional engineered mesoporous silica/inorganic material hybrid nanoparticles: theranostic perspectives |
title_auth |
Multifunctional engineered mesoporous silica/inorganic material hybrid nanoparticles: Theranostic perspectives |
abstract |
The field of advanced nanotechnology is brimming with a plethora of nanotheranostics whose combinatorial synergistic applicability in treating malignant tumors is tremendous. But such multifunctional systems do hold drawbacks that are primarily liable to the inherent nature as well as the properties of the incorporated nanoparticles, which can be effectively tackled by either substituting or incorporating molecules having higher biocompatibility and biodegradability profiles. So, one such sort after, highly exploited inorganic nanocarrier using which theranostic platforms are developed is the Mesoporous Silica Nanoparticle (MSNs), whose amalgamation with upconversion nanoparticles having cutting-edge Near-Infrared imaging proficiency is gaining eminence in biomedicine-based research owing to its exemplary properties in drug targeting, bio-imaging and photodynamic/photothermal therapy, that makes them interesting for further research. MSNs are versatile in aspects related to their pore size and nature, greater drug loading efficiency, and functionalization accentuating their applicability. Several constructive studies with MSNs have been attempted by researchers worldwide, whose manipulation ultimately serves the said purpose of achieving a more holistic approach to treating carcinomas. This article principally sheds light on MSN-based hybrid nanotheranostics such as MSN-Metal Nanoparticles, MSN-Quantum Dots, MSN-Carbon Nanotubes, MSN-Fullerenes, MSN-Graphenes/ Graphene Oxide, MSN-Persistent Luminescence Nanoparticles, and MSN-Carbon-Dots, along with their designing strategies, characterization, applications, in vitro and in vivo efficacy, limitations, biotoxicity as well as the current challenges and future perspectives. |
abstractGer |
The field of advanced nanotechnology is brimming with a plethora of nanotheranostics whose combinatorial synergistic applicability in treating malignant tumors is tremendous. But such multifunctional systems do hold drawbacks that are primarily liable to the inherent nature as well as the properties of the incorporated nanoparticles, which can be effectively tackled by either substituting or incorporating molecules having higher biocompatibility and biodegradability profiles. So, one such sort after, highly exploited inorganic nanocarrier using which theranostic platforms are developed is the Mesoporous Silica Nanoparticle (MSNs), whose amalgamation with upconversion nanoparticles having cutting-edge Near-Infrared imaging proficiency is gaining eminence in biomedicine-based research owing to its exemplary properties in drug targeting, bio-imaging and photodynamic/photothermal therapy, that makes them interesting for further research. MSNs are versatile in aspects related to their pore size and nature, greater drug loading efficiency, and functionalization accentuating their applicability. Several constructive studies with MSNs have been attempted by researchers worldwide, whose manipulation ultimately serves the said purpose of achieving a more holistic approach to treating carcinomas. This article principally sheds light on MSN-based hybrid nanotheranostics such as MSN-Metal Nanoparticles, MSN-Quantum Dots, MSN-Carbon Nanotubes, MSN-Fullerenes, MSN-Graphenes/ Graphene Oxide, MSN-Persistent Luminescence Nanoparticles, and MSN-Carbon-Dots, along with their designing strategies, characterization, applications, in vitro and in vivo efficacy, limitations, biotoxicity as well as the current challenges and future perspectives. |
abstract_unstemmed |
The field of advanced nanotechnology is brimming with a plethora of nanotheranostics whose combinatorial synergistic applicability in treating malignant tumors is tremendous. But such multifunctional systems do hold drawbacks that are primarily liable to the inherent nature as well as the properties of the incorporated nanoparticles, which can be effectively tackled by either substituting or incorporating molecules having higher biocompatibility and biodegradability profiles. So, one such sort after, highly exploited inorganic nanocarrier using which theranostic platforms are developed is the Mesoporous Silica Nanoparticle (MSNs), whose amalgamation with upconversion nanoparticles having cutting-edge Near-Infrared imaging proficiency is gaining eminence in biomedicine-based research owing to its exemplary properties in drug targeting, bio-imaging and photodynamic/photothermal therapy, that makes them interesting for further research. MSNs are versatile in aspects related to their pore size and nature, greater drug loading efficiency, and functionalization accentuating their applicability. Several constructive studies with MSNs have been attempted by researchers worldwide, whose manipulation ultimately serves the said purpose of achieving a more holistic approach to treating carcinomas. This article principally sheds light on MSN-based hybrid nanotheranostics such as MSN-Metal Nanoparticles, MSN-Quantum Dots, MSN-Carbon Nanotubes, MSN-Fullerenes, MSN-Graphenes/ Graphene Oxide, MSN-Persistent Luminescence Nanoparticles, and MSN-Carbon-Dots, along with their designing strategies, characterization, applications, in vitro and in vivo efficacy, limitations, biotoxicity as well as the current challenges and future perspectives. |
collection_details |
GBV_USEFLAG_U SYSFLAG_U GBV_ELV SSG-OLC-PHA GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_32 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_69 GBV_ILN_70 GBV_ILN_73 GBV_ILN_74 GBV_ILN_90 GBV_ILN_95 GBV_ILN_100 GBV_ILN_101 GBV_ILN_105 GBV_ILN_110 GBV_ILN_150 GBV_ILN_151 GBV_ILN_224 GBV_ILN_370 GBV_ILN_602 GBV_ILN_702 GBV_ILN_2003 GBV_ILN_2004 GBV_ILN_2005 GBV_ILN_2011 GBV_ILN_2014 GBV_ILN_2015 GBV_ILN_2020 GBV_ILN_2021 GBV_ILN_2025 GBV_ILN_2027 GBV_ILN_2034 GBV_ILN_2038 GBV_ILN_2044 GBV_ILN_2048 GBV_ILN_2049 GBV_ILN_2050 GBV_ILN_2056 GBV_ILN_2059 GBV_ILN_2061 GBV_ILN_2064 GBV_ILN_2065 GBV_ILN_2068 GBV_ILN_2111 GBV_ILN_2112 GBV_ILN_2113 GBV_ILN_2118 GBV_ILN_2122 GBV_ILN_2129 GBV_ILN_2143 GBV_ILN_2147 GBV_ILN_2148 GBV_ILN_2152 GBV_ILN_2153 GBV_ILN_2190 GBV_ILN_2336 GBV_ILN_2507 GBV_ILN_2522 GBV_ILN_4035 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4242 GBV_ILN_4251 GBV_ILN_4305 GBV_ILN_4313 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4326 GBV_ILN_4333 GBV_ILN_4334 GBV_ILN_4335 GBV_ILN_4338 GBV_ILN_4393 |
title_short |
Multifunctional engineered mesoporous silica/inorganic material hybrid nanoparticles: Theranostic perspectives |
remote_bool |
true |
author2 |
Nayak, Yogendra Garg, Sanjay Nayak, Usha Y |
author2Str |
Nayak, Yogendra Garg, Sanjay Nayak, Usha Y |
ppnlink |
306655020 |
mediatype_str_mv |
c |
isOA_txt |
false |
hochschulschrift_bool |
false |
doi_str |
10.1016/j.ccr.2022.214977 |
up_date |
2024-07-06T21:49:05.627Z |
_version_ |
1803867962085474304 |
fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV009051309</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230524142741.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230510s2022 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.ccr.2022.214977</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV009051309</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0010-8545(22)00572-0</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">540</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">35.00</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Fernandes, Neha Benedicta</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Multifunctional engineered mesoporous silica/inorganic material hybrid nanoparticles: Theranostic perspectives</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2022</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">The field of advanced nanotechnology is brimming with a plethora of nanotheranostics whose combinatorial synergistic applicability in treating malignant tumors is tremendous. But such multifunctional systems do hold drawbacks that are primarily liable to the inherent nature as well as the properties of the incorporated nanoparticles, which can be effectively tackled by either substituting or incorporating molecules having higher biocompatibility and biodegradability profiles. So, one such sort after, highly exploited inorganic nanocarrier using which theranostic platforms are developed is the Mesoporous Silica Nanoparticle (MSNs), whose amalgamation with upconversion nanoparticles having cutting-edge Near-Infrared imaging proficiency is gaining eminence in biomedicine-based research owing to its exemplary properties in drug targeting, bio-imaging and photodynamic/photothermal therapy, that makes them interesting for further research. MSNs are versatile in aspects related to their pore size and nature, greater drug loading efficiency, and functionalization accentuating their applicability. Several constructive studies with MSNs have been attempted by researchers worldwide, whose manipulation ultimately serves the said purpose of achieving a more holistic approach to treating carcinomas. This article principally sheds light on MSN-based hybrid nanotheranostics such as MSN-Metal Nanoparticles, MSN-Quantum Dots, MSN-Carbon Nanotubes, MSN-Fullerenes, MSN-Graphenes/ Graphene Oxide, MSN-Persistent Luminescence Nanoparticles, and MSN-Carbon-Dots, along with their designing strategies, characterization, applications, in vitro and in vivo efficacy, limitations, biotoxicity as well as the current challenges and future perspectives.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Nanotheranostics</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Biocompatibility</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Biodegradability</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Multifunctional systems</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Mesoporous silica nanoparticles</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Upconversion nanoparticles</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Nayak, Yogendra</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Garg, Sanjay</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Nayak, Usha Y</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Coordination chemistry reviews</subfield><subfield code="d">Amsterdam [u.a.] : Elsevier Science, 1966</subfield><subfield code="g">478</subfield><subfield code="h">Online-Ressource</subfield><subfield code="w">(DE-627)306655020</subfield><subfield code="w">(DE-600)1499984-5</subfield><subfield code="w">(DE-576)081985002</subfield><subfield code="x">0010-8545</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:478</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_23</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_31</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_32</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_60</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_62</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_63</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_69</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_70</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_73</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_74</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_90</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_95</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_100</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_101</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_105</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_110</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_150</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_151</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_224</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_370</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_602</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_702</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2003</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2004</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2005</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2011</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2014</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2015</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2020</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2021</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2025</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2027</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2034</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2038</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2044</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2048</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2049</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2050</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2056</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2059</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2061</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2064</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2065</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2068</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2111</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2112</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2113</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2118</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2122</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2129</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2143</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2147</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2148</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2152</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2153</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2190</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2336</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2507</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2522</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4035</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4037</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4112</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4125</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4126</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4242</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4251</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4313</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4323</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4324</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4325</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4326</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4333</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4334</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4335</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4338</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4393</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">35.00</subfield><subfield code="j">Chemie: Allgemeines</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">478</subfield></datafield></record></collection>
|
score |
7.4004374 |